MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Brain iron accumulation"

  • 2022 International Congress

    A Case of Neurodegeneration with Brain Iron Accumulation with novel Adaptor Protein-4 M1 subunit mutation

    A. Battineni, D. Vijayakumar (Greenville, USA)

    Objective: To present a patient with clinical and radiological features of neurodegeneration with brain iron accumulation (NBIA) due to a novel variant mutation in adaptor…
  • 2022 International Congress

    Absence of nigrosome as a finding in a patient with suspected atypical parkinsonism.

    L. Caballero Sánchez, D. Cerdán Santacruz, C. Gómez López, J. Berrío Suaza, P. Gil Armada, M. álvarez Eulate, A. Castrillo Sanz, A. Mendoza Rodriguez, M. Rodríguez Sanz, C. Tabernero García (Segovia, Spain)

    Objective: Reviewing typical neuroimaging features of the substantia nigra.Noting that the absence of nigrosome 1 has also been seen in atypical parkinsonisms. Background: It is…
  • MDS Virtual Congress 2021

    Relationship of subcortical iron deposition and mitochondrial dysfunction in patients with idiopathic Parkinson’s disease

    J. Prasuhn, M. Göttlich, F. Gerkan, S. Kourou, B. Ebeling, M. Kasten, H. Hanssen, C. Klein, N. Brüggemann (Lübeck, Germany)

    Objective: To investigate subcortical brain iron deposition as a potential predictor of the bioenergetic status in patients with idiopathic Parkinson's disease. Background: The underlying pathophysiology…
  • MDS Virtual Congress 2021

    Regional brain iron and gene expression variation in Parkinson’s disease

    G. Thomas, A. Zarkali, M. Ryten, K. Shmueli, AL. Gil Martinez, LA. Leyland, P. Mccolgan, J. Acosta-Cabronero, A. Lees, R. Weil (London, United Kingdom)

    Objective: To shed light on the genes underlying increased cortical iron deposition in Parkinson’s disease (PD). Background: Oxidative stress secondary to brain iron accumulation is…
  • MDS Virtual Congress 2021

    The modification of iron accumulation in nigrosome by levodopa treatment in early Parkinson’s disease

    MD. Wang, HC. Wang, HX. Wang, J. Wang, SJ. Lu, RL. Ge, JB. Chen (Binzhou, China)

    Objective: The study was to investigate the alteration of iron accumulation in nigrosome for the early treatment of dopamine loss in PD. Background: Iron accumulation…
  • MDS Virtual Congress 2021

    A combined imaging based biomarker for Parkinson’s disease using diffusion kurtosis and quantitative susceptibility mapping

    T. Welton, S. Hartono, S. Tan, YC. Shih, W. Lee, S. Chong, S. Ng, N. Chia, EK. Tan, L. Tan, LL. Chan (Singapore, Singapore)

    Objective: We aimed to investigate the utility of combined quantitative susceptibility mapping (QSM) and diffusion kurtosis imaging (DKI) as complementary tools in characterizing pathological changes…
  • MDS Virtual Congress 2021

    SPG21 in Europe: Mutations outside the Amish community

    M. Amprosi, E. Indelicato, A. Eigentler, W. Nachbauer, S. Boesch (Innsbruck, Austria)

    Objective: We herein report two Austrian families harbouring mutations in the SPG21-gene. Background: SPG21 is a complicated, autosomal recessive hereditary spastic paraplegia. It presents with…
  • MDS Virtual Congress 2021

    PLA2G6-Associated Neurodegeneration: A Continuum of Phenotypes

    D. Shah-Zamora, M. Bailey (Chicago, USA)

    Objective: To characterize the spectrum of phenotypes of PLA2G6-associated neurodegeneration in a single patient. Background: The phospholipase A2 Group VI (PLA2G6) gene encodes a cytosolic and…
  • MDS Virtual Congress 2021

    Non-invasive imaging markers of iron accumulation in Multiple System Atrophy

    D. Claassen, P. Trujillo, D. Buchanan, K. Hett, C. Wong, D. Stamler (Nashville, USA)

    Objective: To define the localization and extent of iron accumulation in multiple system atrophy (MSA). Background: Elevated iron concentration in the basal ganglia has been…
  • MDS Virtual Congress 2021

    Novel PLA2G6 Mutation Presenting as Early-Onset Parkinson’s Disease

    J. Hislop, E. Saraf Lavi, D. Barbouth, M. Foley, H. Moore, C. Singer (Miami, USA)

    Objective: To report a case of a novel mutation in the PLA2G6 gene resulting in early-onset Parkinson’s Disease. Background: The phospholipase A2 group VI (PLA2G6)…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • …
  • 8
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley